edaravone
- Strength
- 30 mg/100mL
- Form
- Injection, Solution
Gland Pharma Limited
Listed by XGen Pharmaceuticals DJB, Inc.
| Dosage form | Injection, Solution |
|---|---|
| Route | Intravenous |
| Approval route | ANDA — approved generic |
| NDC code | 39822-4510 |
| FDA application | ANDA217565 |
| RxNorm concept | 1924316 |
| Package sizes listed | 1 |
| Marketed since | December 2024 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.